Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00345930 · ClinicalTrials.gov registry record
DILIN - Prospective Study
A clinical trial of Liver Diseases, sponsored by Duke University.
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 6
- Study locations
NCT00345930: Recruiting study of Liver Diseases, sponsored by Duke University.
NCT00345930 is a study of Liver Diseases that is actively recruiting participants, run by Duke University. The registered enrollment target is 4,000 participants, below the 61,037-participant average among 33 other Liver Diseases trials with a reported enrollment target (93% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00345930, a study of Liver Diseases, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to identify individuals who have suffered a liver injury arising as an idiosyncratic reaction to a prescription drug or a complementary and alternative medicine. Recently added acute cases enrollment that meets criteria to the protocol. Also added Fibroscans to the protocol that will be completed at baseline and follow-up on chronic subjects.
Primary Outcome
develop a database of recent DILI cases
Conditions Studied
Study Locations (6)
California
- University of Southern California - Los Angeles
Indiana
- Indiana University - Indianapolis
Maryland
- NIH Clinical Site - Bethesda
Michigan
- University of Michigan - Ann Arbor
North Carolina
- Univeristy of North Carolina at Chapel Hill - Chapel Hill
Pennsylvania
- Thomas Jefferson - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2004-09 |
| Est. Completion | 2028-07-31 |
What NCT00345930 shows while recruiting
NCT00345930 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, below the 61,037-participant average among 33 other Liver Diseases trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Liver Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT00345930 lists 6 locations in 6 states (California, Indiana, Maryland).
Frequently Asked Questions
What is clinical trial NCT00345930 about?
NCT00345930 is a clinical study titled "DILIN - Prospective Study". The purpose of this study is to identify individuals who have suffered a liver injury arising as an idiosyncratic reaction to a prescription drug or a complementary and alternative medicine. Recently added acute cases enrollment that meets criteria to the protocol. Also added Fibroscans to the proto...
What is the current status of trial NCT00345930?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2004-09. Estimated completion is 2028-07-31.
What conditions does trial NCT00345930 study?
This clinical trial studies the following conditions: Liver Diseases.
Who is sponsoring clinical trial NCT00345930?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00345930 being conducted?
This trial has 6 study locations across California, Indiana, Maryland, Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00345930's enrollment target sits among peer trials
4,000 2nd of 33 the highest of 33 other Liver Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)
RECRUITING · NA
-
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
RECRUITING · NA
-
MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease
RECRUITING
-
The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial
RECRUITING · Phase 1
-
Genetic Collection Protocol
RECRUITING
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia